NCT02711202 2025-06-04
Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation
Institute for Clinical and Experimental Medicine
Phase NA Completed
Clinical Trials
6 trialsNCT00578292 2020-05-01
THALLO
Baylor College of Medicine
Phase NA Terminated
NCT00578539 2016-04-22
REGALE
Baylor College of Medicine
Phase NA Terminated
NCT00587847 2015-10-15
Campath Maintenance in Chronic Lymphocytic Leukemia
Northwell Health
Phase NA Terminated
NCT00525876 2011-12-07
Non-Myeloablative Allogeneic Stem Cell Transplantation
M.D. Anderson Cancer Center
Phase NA Completed
NCT00582894 2011-04-22
Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Malignant Hematological Diseases
University of Oklahoma
Phase NA Completed